OPKO Health, Inc. Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31)
OPKO Health, Inc. (OPK) reported Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) of -$21.90 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss · last filed 2020-05-06
- OPKO Health, Inc. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2020-03-31 was -$21.90M.
- OPKO Health, Inc. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-12-31 was -$20.80M.
- OPKO Health, Inc. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-09-30 was -$18.80M.
- OPKO Health, Inc. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-06-30 was $12.00M.
- OPKO Health, Inc. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2019 was -$62.90M.
- OPKO Health, Inc. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2018 was -$179.80M.
- OPKO Health, Inc. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2016 was -$208.10M.
- OPKO Health, Inc. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2015 was -$73.30M.
| Period end | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$21.90M 10-Q · filed 2020-05-06 | -$42.70M derived: sum of 2 quarters · filed 2020-05-06 | -$61.50M derived: sum of 3 quarters · filed 2020-05-06 | -$49.50M derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | -$20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$39.60M derived: sum of 2 quarters · filed 2020-03-02 | -$27.60M derived: sum of 3 quarters · filed 2020-03-02 | -$62.90M 10-K · filed 2020-03-02 |
| 2019-09-30 | -$18.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$6.80M derived: sum of 2 quarters · filed 2019-11-05 | -$42.10M 10-Q · filed 2019-11-05 | -$43.90M derived: sum of 4 quarters · filed 2019-11-05 |
| 2019-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$23.30M 10-Q · filed 2019-08-07 | -$25.10M derived: sum of 3 quarters · filed 2019-08-07 | -$59.60M derived: sum of 4 quarters · filed 2019-08-07 |
| 2019-03-31 | -$35.30M 10-Q · filed 2019-05-08 | -$37.10M derived: sum of 2 quarters · filed 2019-05-08 | -$71.60M derived: sum of 3 quarters · filed 2019-05-08 | -$194.30M derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | -$1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$36.30M derived: sum of 2 quarters · filed 2019-03-01 | -$159.00M derived: sum of 3 quarters · filed 2019-03-01 | -$179.80M 10-K · filed 2019-03-01 |
| 2018-09-30 | -$34.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$157.20M derived: sum of 2 quarters · filed 2018-11-09 | -$178.00M 10-Q · filed 2018-11-09 | $59.00M derived: sum of 4 quarters · filed 2019-01-29 |
| 2018-06-30 | -$122.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$143.50M 10-Q · filed 2018-08-07 | $93.50M derived: sum of 3 quarters · filed 2019-01-29 | $44.90M derived: sum of 4 quarters · filed 2019-01-29 |
| 2018-03-31 | -$20.80M 10-Q · filed 2018-05-08 | $216.20M derived: sum of 2 quarters · filed 2019-01-29 | $167.60M derived: sum of 3 quarters · filed 2019-01-29 | $169.60M derived: sum of 4 quarters · filed 2019-01-29 |
| 2017-12-31 | $237.00M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $188.40M derived: sum of 2 quarters · filed 2019-01-29 | $190.40M derived: sum of 3 quarters · filed 2019-01-29 | $130.90M 8-K · filed 2019-01-29 |
| 2017-09-30 | -$48.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$46.60M derived: sum of 2 quarters · filed 2017-11-08 | -$106.10M 10-Q · filed 2017-11-08 | -$181.90M derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$57.50M 10-Q · filed 2017-08-08 | -$133.30M derived: sum of 3 quarters · filed 2017-08-08 | -$139.90M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | -$59.50M 10-Q · filed 2017-05-10 | -$135.30M derived: sum of 2 quarters · filed 2017-05-10 | -$141.90M derived: sum of 3 quarters · filed 2017-05-10 | -$236.30M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | -$75.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$82.40M derived: sum of 2 quarters · filed 2017-03-01 | -$176.80M derived: sum of 3 quarters · filed 2017-03-01 | -$208.10M 10-K · filed 2017-03-01 |
| 2016-09-30 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$101.00M derived: sum of 2 quarters · filed 2016-11-07 | -$132.30M 10-Q · filed 2016-11-07 | -$141.30M derived: sum of 4 quarters · filed 2016-11-07 |
| 2016-06-30 | -$94.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$125.70M 10-Q · filed 2016-08-08 | -$134.70M derived: sum of 3 quarters · filed 2016-08-08 | -$146.50M derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | -$31.30M 10-Q · filed 2016-05-09 | -$40.30M derived: sum of 2 quarters · filed 2016-05-09 | -$52.10M derived: sum of 3 quarters · filed 2016-05-09 | -$66.80M derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$20.80M derived: sum of 2 quarters · filed 2016-02-29 | -$35.50M derived: sum of 3 quarters · filed 2016-02-29 | -$73.30M 10-K · filed 2016-02-29 |
| 2015-09-30 | -$11.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$26.50M derived: sum of 2 quarters · filed 2015-11-09 | -$64.30M 10-Q · filed 2015-11-09 | -$151.50M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | -$14.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$52.50M 10-Q · filed 2015-08-05 | -$139.70M derived: sum of 3 quarters · filed 2015-08-05 | -$133.60M derived: sum of 4 quarters · filed 2015-08-05 |
| 2015-03-31 | -$37.80M 10-Q · filed 2015-05-11 | -$125.00M derived: sum of 2 quarters · filed 2015-05-11 | -$118.90M derived: sum of 3 quarters · filed 2015-05-11 | -$106.20M derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | -$87.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$81.10M derived: sum of 2 quarters · filed 2015-02-27 | -$68.40M derived: sum of 3 quarters · filed 2015-02-27 | -$55.90M 10-K · filed 2015-02-27 |
| 2014-09-30 | $6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $18.80M derived: sum of 2 quarters · filed 2014-11-07 | $31.30M 10-Q · filed 2014-11-07 | $157.60M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | $12.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $25.20M 10-Q · filed 2014-08-11 | $151.50M derived: sum of 3 quarters · filed 2014-08-11 | $134.10M derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | $12.50M 10-Q · filed 2014-05-09 | $138.80M derived: sum of 2 quarters · filed 2014-05-09 | $121.40M derived: sum of 3 quarters · filed 2014-05-09 | $66.60M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | $126.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $108.90M derived: sum of 2 quarters · filed 2014-03-03 | $54.10M derived: sum of 3 quarters · filed 2014-03-03 | $75.10M 10-K · filed 2014-03-03 |
| 2013-09-30 | -$17.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$72.20M derived: sum of 2 quarters · filed 2013-11-12 | -$51.20M 10-Q · filed 2013-11-12 | -$49.20M derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | -$54.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$33.80M 10-Q · filed 2013-08-09 | -$31.80M derived: sum of 3 quarters · filed 2013-08-09 | -$28.20M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $21.00M 10-Q · filed 2013-05-10 | $23.00M derived: sum of 2 quarters · filed 2013-05-10 | $26.60M derived: sum of 3 quarters · filed 2013-05-10 | |
| 2012-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $5.60M derived: sum of 2 quarters · filed 2013-03-18 | $13.40M 10-K · filed 2013-03-18 | |
| 2012-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $11.40M 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | $7.80M 10-Q · filed 2012-08-09 | |||
| 2011-12-31 | $9.10M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |